Myriad Genetics Inc (NAS:MYGN)
$ 26.84 0.45 (1.71%) Market Cap: 2.44 Bil Enterprise Value: 2.44 Bil PE Ratio: 0 PB Ratio: 3.29 GF Score: 78/100

Myriad Genetics Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript

May 12, 2021 / 06:45PM GMT
Release Date Price: $25.4 (+0.04%)
Derik De Bruin
BofA Securities, Research Division - MD of Equity Research

Good afternoon, everyone. I'm Derik De Bruin, the senior life sciences and diagnostic tools analyst from Bank of America. Welcome to our 2021 BofA Virtual Las Vegas Health Care Conference. My colleague, Ivy Ma is on. And joining us today is Myriad Genetics. We have Paul Diaz, Chief Executive Officer; Bryan Riggsbee, Chief Financial Officer. Paul, Bryan, thanks for being here.

Paul J. Diaz
Myriad Genetics, Inc. - CEO, President & Director

Thank you, Derik. Thanks, Ivy. Appreciate the opportunity.

Questions & Answers

Derik De Bruin
BofA Securities, Research Division - MD of Equity Research

So Paul, I'm going to kick it off to you first. You had an Analyst Day last week where you outlined some of the changes going on in the company. So I want to first focus on those. But first, let's just sort of look -- you're approaching our 1-year anniversary since your arrival in company. You've under -- you've begun a big transformation of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot